top 10 innovations 2012, genetics & genomics, immunology
Contributors
Contributors
Catherine Offord | Jun 1, 2016
Meet some of the people featured in the June 2016 issue of The Scientist.
Screening  with CRISPR
Screening with CRISPR
Kelly Rae Chi | Jun 1, 2016
Ever-improving CRISPR-based tools are already ripe for large-scale genetic screens.
Do Patents Promote or Stall Innovation?
Do Patents Promote or Stall Innovation?
Catherine Offord | Jun 1, 2016
A petition recently filed with the Supreme Court triggers renewed debate about the role of patents in the diagnostics sector.
Building Gene Networks
Building Gene Networks
Richard A. Muscat | Jun 1, 2016
Synthetic biologists use natural genetic motifs to construct novel circuits.
Finding Mislabeled Noncoding RNAs
Finding Mislabeled Noncoding RNAs
Ruth Williams | Jun 1, 2016
Researchers scour the genome for micropeptides encoded within RNAs presumed to function in a noncoding capacity.
Synthetic Biology Comes into Its Own
Synthetic Biology Comes into Its Own
Richard A. Muscat | Jun 1, 2016
Researchers create novel genetic circuits that give insight into, and are inspired by, nature.
Noncoding RNAs Not So Noncoding
Noncoding RNAs Not So Noncoding
Ruth Williams | Jun 1, 2016
Bits of the transcriptome once believed to function as RNA molecules are in fact translated into small proteins.
Toward Targeted Therapies for Autoimmune Disorders
Toward Targeted Therapies for Autoimmune Disorders
Lawrence Steinman | Jun 1, 2016
Training the immune system to cease fire on native tissues could improve outcomes for autoimmune patients, but clinical progress has been slow.
FDA Approves Bladder Cancer Immunotherapy
FDA Approves Bladder Cancer Immunotherapy
Jef Akst | May 23, 2016
The US Food and Drug Administration greenlights Roche’s Tecentriq, which blocks a protein that obstructs the immune system’s ability to fight cancer.
Broad-Spectrum Antibiotics Can Increase GVHD Severity in Stem Cell Recipients
Broad-Spectrum Antibiotics Can Increase GVHD Severity in Stem Cell Recipients
Ruth Williams | May 18, 2016
Certain drugs could worsen graft-versus-host disease in stem cell transplant patients, scientists show.